Anke Morgner
Chemnitz, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Haploidentical Allogeneic Cell Transplantation in Relapsed/Refractory Multiple Myeloma.
Journal: Cancer management and research
Published: September 01, 2025
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.
Journal: Blood cancer journal
Published: January 07, 2025
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?
Journal: Annals of hematology
Published: June 07, 2024
Challenges in the treatment of soft-tissue plasmacytoma: a retrospective analysis of 120 patients with extramedullary multiple myeloma.
Journal: Journal of cancer research and clinical oncology
Published: May 15, 2024
Real-world analysis of teclistamab in 123 RRMM patients from Germany.
Journal: Leukemia
Published: November 10, 2023
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial.
Journal: Nature cancer
Published: September 16, 2022
Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.
Journal: Cancer management and research
Published: September 19, 2021
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
Journal: Blood cancer journal
Published: July 08, 2021
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP.
Journal: Blood advances
Published: April 02, 2020
Last Updated: 09/26/2026